ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Van de Werf, 2008, Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology, Eur Heart J, 29, 2909, 10.1093/eurheartj/ehn416
Thygesen, 2007, Universal definition of myocardial infarction, Eur Heart J, 28, 2525, 10.1093/eurheartj/ehm355
Hamm, 2011, ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J, 32, 2999, 10.1093/eurheartj/ehr236
Wijns, 2010, Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, 31, 2501, 10.1093/eurheartj/ehq277
Widimsky, 2010, Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries, Eur Heart J, 31, 943, 10.1093/eurheartj/ehp492
Widimsky, 2007, “reperfusion network” of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry, Int J Cardiol, 119, 212, 10.1016/j.ijcard.2007.02.036
McManus, 2011, Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI, Am J Med, 124, 40, 10.1016/j.amjmed.2010.07.023
Roger, 2012, Executive summary: heart disease and stroke statistics—2012 update: a report from the American Heart Association, Circulation, 125, 188, 10.1161/CIR.0b013e3182456d46
Mandelzweig, 2006, The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004, Eur Heart J, 27, 2285, 10.1093/eurheartj/ehl196
Jernberg, 2011, Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction, J Am Med Assoc, 305, 1677, 10.1001/jama.2011.522
Fox, 2007, Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006, J Am Med Assoc, 297, 1892, 10.1001/jama.297.17.1892
Fox, 2006, Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE), Br Med J, 333, 1091, 10.1136/bmj.38985.646481.55
Fox, 2010, Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK–Belgian Study), Eur Heart J, 31, 2755, 10.1093/eurheartj/ehq326
Tubaro, 2011, Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology, Acute Card Care, 13, 56, 10.3109/17482941.2011.581292
Brieger, 2004, Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events, Chest, 126, 461, 10.1378/chest.126.2.461
Diercks, 2006, Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative), Am J Cardiol, 97, 437, 10.1016/j.amjcard.2005.09.073
Lopez-Sendon, 1985, Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3, J Am Coll Cardiol, 6, 1273, 10.1016/S0735-1097(85)80213-8
Rokos, 2009, Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on door-to-balloon times across 10 independent regions, JACC Cardiovasc Interv, 2, 339, 10.1016/j.jcin.2008.11.013
O'Doherty, 1983, Five hundred patients with myocardial infarction monitored within one hour of symptoms, Br Med J (Clin Res Ed), 286, 1405, 10.1136/bmj.286.6375.1405
Mehta, 2009, Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention, J Am Med Assoc, 301, 1779, 10.1001/jama.2009.600
Sgarbossa, 1996, Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) investigators, N Engl J Med, 334, 481, 10.1056/NEJM199602223340801
Shlipak, 1999, Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction?, JAMA, 281, 714, 10.1001/jama.281.8.714
Lopes, 2011, Diagnosing acute myocardial infarction in patients with left bundle branch block, Am J Cardiol, 108, 782, 10.1016/j.amjcard.2011.05.006
Widimsky, 2012, Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?, Eur Heart J, 33, 86, 10.1093/eurheartj/ehr291
Krishnaswamy, 2009, Magnitude and consequences of missing the acute infarct-related circumflex artery, Am Heart J, 158, 706, 10.1016/j.ahj.2009.08.024
From, 2010, Acute myocardial infarction due to left circumflex artery occlusion and significance of ST-segment elevation, Am J Cardiol, 106, 1081, 10.1016/j.amjcard.2010.06.016
Yan, 2007, Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes, Am Heart J, 154, 71, 10.1016/j.ahj.2007.03.037
Akashi, 2008, Takotsubo cardiomyopathy: a new form of acute, reversible heart failure, Circulation, 118, 2754, 10.1161/CIRCULATIONAHA.108.767012
Cabello, 2010, Oxygen therapy for acute myocardial infarction, Cochrane Database Syst Rev, 6, 10.1002/14651858.CD007160.pub2
Spaulding, 1997, Immediate coronary angiography in survivors of out-of-hospital cardiac arrest, N Engl J Med, 336, 1629, 10.1056/NEJM199706053362302
Kern, 2010, Emergent percutaneous coronary intervention for resuscitated victims of out-of-hospital cardiac arrest, Catheter Cardiovasc Interv, 75, 616, 10.1002/ccd.22192
Garot, 2007, Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction, Circulation, 115, 1354, 10.1161/CIRCULATIONAHA.106.657619
Bernard, 2002, Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia, N Engl J Med, 346, 557, 10.1056/NEJMoa003289
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest, 2002, N Engl J Med, 346, 549, 10.1056/NEJMoa012689
Belliard, 2007, Efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation, Resuscitation, 75, 252, 10.1016/j.resuscitation.2007.04.014
Nolan, 2010, European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary, Resuscitation, 81, 1219, 10.1016/j.resuscitation.2010.08.021
Luepker, 2000, Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial, JAMA, 284, 60, 10.1001/jama.284.1.60
Terkelsen, 2010, System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention, JAMA, 304, 763, 10.1001/jama.2010.1139
Steg, 2003, Impact of time to treatment on mortality after pre-hospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial, Circulation, 108, 2851, 10.1161/01.CIR.0000103122.10021.F2
Pinto, 2006, Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy, Circulation, 114, 2019, 10.1161/CIRCULATIONAHA.106.638353
Huber, 2005, Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction, Eur Heart J, 26, 2063, 10.1093/eurheartj/ehi413
Welsh, 2005, Time to treatment and the impact of a physician on pre-hospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial, Heart, 91, 1400, 10.1136/hrt.2004.054510
Danchin, 2008, Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French registry on acute ST-elevation myocardial infarction (FAST-MI), Circulation, 118, 268, 10.1161/CIRCULATIONAHA.107.762765
Bonnefoy, 2009, Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up, Eur Heart J, 30, 1598, 10.1093/eurheartj/ehp156
McMullan, 2012, Ground emergency medical services requests for helicopter transfer of ST-segment elevation myocardial infarction patients decrease medical contact to balloon times in rural and suburban settings, Acad Emerg Med, 19, 153, 10.1111/j.1553-2712.2011.01273.x
Kalla, 2006, Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry), Circulation, 113, 2398, 10.1161/CIRCULATIONAHA.105.586198
Henry, 2007, A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction, Circulation, 116, 721, 10.1161/CIRCULATIONAHA.107.694141
Le May, 2008, A citywide protocol for primary PCI in ST-segment elevation myocardial infarction, N Engl J Med, 358, 231, 10.1056/NEJMoa073102
Bradley, 2006, Strategies for reducing the door-to-balloon time in acute myocardial infarction, N Engl J Med, 355, 2308, 10.1056/NEJMsa063117
Widimsky, 2009, “Stent 4 Life” targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac Care, EuroIntervention, 4, 557
Knot, 2009, How to set up an effective national primary angioplasty network: lessons learned from five European countries, EuroIntervention, 5, 301
Ting, 2008, Implementation and integration of pre-hospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology, Circulation, 118, 1066, 10.1161/CIRCULATIONAHA.108.190402
Amit, 2007, Benefit of direct ambulance to coronary care unit admission of acute myocardial infarction patients undergoing primary percutaneous intervention, Int J Cardiol, 119, 355, 10.1016/j.ijcard.2006.08.009
Nallamothu, 2007, Development of systems of care for ST-elevation myocardial infarction patients: gaps, barriers, and implications, Circulation, 116, 10.1161/CIRCULATIONAHA.107.184052
Rathore, 2009, Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study, Br Med J, 338, 10.1136/bmj.b1807
Nielsen, 2011, System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial), Am J Cardiol, 108, 776, 10.1016/j.amjcard.2011.05.007
Steg, 2006, Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry, Heart, 92, 1378, 10.1136/hrt.2006.101972
Hackett, 1987, Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy, N Engl J Med, 317, 1055, 10.1056/NEJM198710223171704
Schomig, 2005, Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial, JAMA, 293, 2865, 10.1001/jama.293.23.2865
Ndrepepa, 2009, Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms, JAMA, 301, 487, 10.1001/jama.2009.32
Hochman, 2006, Coronary intervention for persistent occlusion after myocardial infarction, N Engl J Med, 355, 2395, 10.1056/NEJMoa066139
Ioannidis, 2007, Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients, Am Heart J, 154, 1065, 10.1016/j.ahj.2007.07.049
Menon, 2009, Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial, Eur Heart J, 30, 183, 10.1093/eurheartj/ehn486
Boersma, 1996, Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour, Lancet, 348, 771, 10.1016/S0140-6736(96)02514-7
Boersma, 2006, Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients, Eur Heart J, 27, 779, 10.1093/eurheartj/ehi810
Gierlotka, 2011, Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]), Am J Cardiol, 107, 501, 10.1016/j.amjcard.2010.10.008
Zijlstra, 1999, Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction, N Engl J Med, 341, 1413, 10.1056/NEJM199911043411901
Keeley, 2003, Primary angioplasty vs. intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet, 361, 13, 10.1016/S0140-6736(03)12113-7
Widimsky, 2003, Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial—PRAGUE-2, Eur Heart J, 24, 94, 10.1016/S0195-668X(02)00468-2
Andersen, 2003, A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction, N Engl J Med, 349, 733, 10.1056/NEJMoa025142
Morrison, 2000, Mortality and pre-hospital thrombolysis for acute myocardial infarction: A meta-analysis, JAMA, 283, 2686, 10.1001/jama.283.20.2686
Bonnefoy, 2002, Primary angioplasty vs. pre-hospital fibrinolysis in acute myocardial infarction: a randomised study, Lancet, 360, 825, 10.1016/S0140-6736(02)09963-4
Pinto, 2011, Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase, Circulation, 124, 2512, 10.1161/CIRCULATIONAHA.111.018549
Widimsky, 2011, How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?, Eur Heart J, 32, 396, 10.1093/eurheartj/ehq410
Cavender, 2009, Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry), Am J Cardiol, 104, 507, 10.1016/j.amjcard.2009.04.016
Kornowski, 2011, Prognostic impact of staged vs. “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevascularIZatiON and stents in Acute Myocardial Infarction) trial, J Am Coll Cardiol, 58, 704, 10.1016/j.jacc.2011.02.071
Jolly, 2011, Radial vs. femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial, Lancet, 377, 1409, 10.1016/S0140-6736(11)60404-2
Romagnoli, 2012, Radial vs. femoral randomized investigation in ST elevation acute coronary syndromes: The RIFLE STEACS study, J Am Coll Cardiol, 10.1016/j.jacc.2012.06.017
Kastrati, 2007, Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction, Eur Heart J, 28, 2706, 10.1093/eurheartj/ehm402
Piccolo, 2011, Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials, Atherosclerosis, 217, 149, 10.1016/j.atherosclerosis.2011.03.007
Stone, 2011, Heparin plus a glycoprotein IIb/IIIa inhibitor vs. bivalirudin monotherapy and paclitaxel-eluting stents vs. bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial, Lancet, 377, 2193, 10.1016/S0140-6736(11)60764-2
Svilaas, 2008, Thrombus aspiration during primary percutaneous coronary intervention, N Engl J Med, 358, 557, 10.1056/NEJMoa0706416
Vlaar, 2008, Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study, Lancet, 371, 1915, 10.1016/S0140-6736(08)60833-8
Burzotta, 2009, Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials, Eur Heart J, 30, 2193, 10.1093/eurheartj/ehp348
Bavry, 2008, Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials, Eur Heart J, 29, 2989, 10.1093/eurheartj/ehn421
Stone, 2012, Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial, JAMA, 307, 1817, 10.1001/jama.2012.421
Frobert, 2010, Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale, Am Heart J, 160, 1042, 10.1016/j.ahj.2010.08.040
Botker, 2010, Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial, Lancet, 375, 727, 10.1016/S0140-6736(09)62001-8
Staat, 2005, Postconditioning the human heart, Circulation, 112, 2143, 10.1161/CIRCULATIONAHA.105.558122
Thibault, 2008, Long-term benefit of postconditioning, Circulation, 117, 1037, 10.1161/CIRCULATIONAHA.107.729780
Piot, 2008, Effect of cyclosporine on reperfusion injury in acute myocardial infarction, N Engl J Med, 359, 473, 10.1056/NEJMoa071142
Sorensson, 2010, Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction, Heart, 96, 1710, 10.1136/hrt.2010.199430
Freixa, 2012, Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention, Eur Heart J, 33, 103, 10.1093/eurheartj/ehr297
Lonborg, 2010, Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance, Circ Cardiovasc Interv, 3, 34, 10.1161/CIRCINTERVENTIONS.109.905521
Patel, 2011, Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial, JAMA, 306, 1329, 10.1001/jama.2011.1280
Sjauw, 2009, A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?, Eur Heart J, 30, 459, 10.1093/eurheartj/ehn602
Cucherat, 2003, Primary angioplasty vs. intravenous thrombolysis for acute myocardial infarction, Cochrane Database Syst Rev, 10.1002/14651858.CD001560.pub2
Hochman, 1999, Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock, N Engl J Med, 341, 625, 10.1056/NEJM199908263410901
Nordmann, 2004, Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials, Am J Med, 116, 253, 10.1016/j.amjmed.2003.08.035
Stone, 1999, Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial, Circulation, 99, 1548, 10.1161/01.CIR.99.12.1548
Hannan, 2010, Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease, JACC Cardiovasc Interv, 3, 22, 10.1016/j.jcin.2009.10.017
Toma, 2010, Hamm CW, Granger CB, Armstrong PW. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial, Eur Heart J, 31, 1701, 10.1093/eurheartj/ehq129
Vlaar, 2011, Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis, J Am Coll Cardiol, 58, 692, 10.1016/j.jacc.2011.03.046
Wijnbergen, 2012, Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study, JACC Cardiovasc Interv, 5, 313, 10.1016/j.jcin.2011.11.009
De Luca, 2012, Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials, Arch Intern Med, 172, 611, 10.1001/archinternmed.2012.758
Kelbaek, 2008, Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial, J Am Coll Cardiol, 51, 899, 10.1016/j.jacc.2007.10.047
Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482
Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327
Montalescot, 2009, Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial, Lancet, 373, 723, 10.1016/S0140-6736(09)60441-4
Steg, 2010, Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis, Circulation, 122, 2131, 10.1161/CIRCULATIONAHA.109.927582
Storey, 2011, Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes, Eur Heart J, 32, 2945, 10.1093/eurheartj/ehr231
Mehta, 2010, Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial, Lancet, 376, 1233, 10.1016/S0140-6736(10)61088-4
Koul, 2011, Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, Eur Heart J, 32, 2989, 10.1093/eurheartj/ehr202
Dorler, 2011, Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction, Eur Heart J, 32, 2954, 10.1093/eurheartj/ehr360
Yusuf, 2006, Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial, JAMA, 295, 1519, 10.1001/jama.295.13.joc60038
Silvain, 2012, Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis, Br Med J, 344, e553, 10.1136/bmj.e553
Montalescot, 2010, Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events), JACC Cardiovasc Interv, 3, 203, 10.1016/j.jcin.2009.11.012
Navarese, 2011, Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis, J Thromb Haemost, 9, 1902, 10.1111/j.1538-7836.2011.04445.x
Montalescot, 2011, Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial, Lancet, 378, 693, 10.1016/S0140-6736(11)60876-3
Mehran, 2009, Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial, Lancet, 374, 1149, 10.1016/S0140-6736(09)61484-7
Stone, 2008, Bivalirudin during primary PCI in acute myocardial infarction, N Engl J Med, 358, 2218, 10.1056/NEJMoa0708191
Dangas, 2011, Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction, Circulation, 123, 1745, 10.1161/CIRCULATIONAHA.110.981688
De Luca, 2009, Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials, Eur Heart J, 30, 2705, 10.1093/eurheartj/ehp118
Ellis, 2008, Facilitated PCI in patients with ST-elevation myocardial infarction, N Engl J Med, 358, 2205, 10.1056/NEJMoa0706816
Herrmann, 2009, Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals, JACC Cardiovasc Interv, 2, 917, 10.1016/j.jcin.2009.06.018
ten Berg, 2010, Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome, J Am Coll Cardiol, 55, 2446, 10.1016/j.jacc.2009.11.091
Mehilli, 2009, Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial, Circulation, 119, 1933, 10.1161/CIRCULATIONAHA.108.818617
Friedland, 2011, Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome, Am J Cardiol, 108, 1244, 10.1016/j.amjcard.2011.06.039
Thiele, 2012, Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial, Lancet, 379, 923, 10.1016/S0140-6736(11)61872-2
1988, Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group, Lancet, 2, 349
Patrono, 2011, Antiplatelet agents for the treatment and prevention of atherothrombosis, Eur Heart J, 32, 2922, 10.1093/eurheartj/ehr373
Leon, 1998, A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators, N Engl J Med, 339, 1665, 10.1056/NEJM199812033392303
Schomig, 1996, A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents, N Engl J Med, 334, 1084, 10.1056/NEJM199604253341702
De Luca, 2005, Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials, JAMA, 293, 1759, 10.1001/jama.293.14.1759
Zeymer, 2010, Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial, J Am Coll Cardiol, 56, 463, 10.1016/j.jacc.2009.08.093
Akerblom, 2010, Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry), J Am Coll Cardiol, 56, 470, 10.1016/j.jacc.2009.10.093
Van't Hof, 2008, Pre-hospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial, Lancet, 372, 537, 10.1016/S0140-6736(08)61235-0
Valgimigli, 2010, Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials, Eur Heart J, 31, 35, 10.1093/eurheartj/ehp376
De Luca, 2011, Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis, J Thromb Haemost, 9, 2361, 10.1111/j.1538-7836.2011.04513.x
2006, Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial, Lancet, 367, 569, 10.1016/S0140-6736(06)68147-6
Sorajja, 2005, Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction, Eur Heart J, 26, 667, 10.1093/eurheartj/ehi167
Fokkema, 2009, Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction, Eur Heart J, 30, 908, 10.1093/eurheartj/ehp033
1994, Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, Lancet, 343, 311, 10.1016/S0140-6736(94)91161-4
Armstrong, 2010, The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study, Am Heart J, 160, 10.1016/j.ahj.2010.04.007
Van de Werf, 2001, Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA, Eur Heart J, 22, 2253, 10.1053/euhj.2001.2686
Van De Werf, 1999, Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, Lancet, 354, 716, 10.1016/S0140-6736(99)07403-6
A comparison of reteplase with alteplase for acute myocardial infarction, 1997, The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators, N Engl J Med, 337, 1118
Berkowitz, 1997, Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators, Circulation, 95, 2508, 10.1161/01.CIR.95.11.2508
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction, 1993, The GUSTO investigators, N Engl J Med, 329, 673
Bottiger, 2008, Thrombolysis during resuscitation for out-of-hospital cardiac arrest, N Engl J Med, 359, 2651, 10.1056/NEJMoa070570
Bjorklund, 2006, Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction, Eur Heart J, 27, 1146, 10.1093/eurheartj/ehi886
Chen, 2005, Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet, 366, 1607, 10.1016/S0140-6736(05)67660-X
Sabatine, 2005, Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation, N Engl J Med, 352, 1179, 10.1056/NEJMoa050522
2001, Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction, Lancet, 358, 605, 10.1016/S0140-6736(01)05775-0
Wallentin, 2003, Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the pre-hospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction, Circulation, 108, 135, 10.1161/01.CIR.0000081659.72985.A8
Giraldez, 2007, Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis, Eur Heart J, 28, 1566, 10.1093/eurheartj/ehm179
White, 2007, Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25, Eur Heart J, 28, 1066, 10.1093/eurheartj/ehm081
Ross, 2001, Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II), Circulation, 104, 648, 10.1161/hc3101.093866
Antman, 2002, Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial, Circulation, 105, 1642, 10.1161/01.CIR.0000013402.34759.46
Peters, 2008, The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial, Eur Heart J, 29, 324, 10.1093/eurheartj/ehm616
Gershlick, 2005, Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction, N Engl J Med, 353, 2758, 10.1056/NEJMoa050849
Ellis, 1994, Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction, Circulation, 90, 2280, 10.1161/01.CIR.90.5.2280
Hochman, 2001, One-year survival following early revascularization for cardiogenic shock, JAMA, 285, 190, 10.1001/jama.285.2.190
Cantor, 2009, Routine early angioplasty after fibrinolysis for acute myocardial infarction, N Engl J Med, 360, 2705, 10.1056/NEJMoa0808276
Di Mario, 2008, Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial, Lancet, 371, 559, 10.1016/S0140-6736(08)60268-8
Bohmer, 2010, Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction), J Am Coll Cardiol, 55, 102, 10.1016/j.jacc.2009.08.007
Fernandez-Aviles, 2004, Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial, Lancet, 364, 1045, 10.1016/S0140-6736(04)17059-1
Borgia, 2010, Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis, Eur Heart J, 31, 2156, 10.1093/eurheartj/ehq204
Sanchez, 2010, Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial, Circ Cardiovasc Interv, 3, 297, 10.1161/CIRCINTERVENTIONS.109.920868
de Bono, 1992, Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial, Br Heart J, 67, 122, 10.1136/hrt.67.2.122
1993, The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators, N Engl J Med, 329, 1615, 10.1056/NEJM199311253292204
White, 2001, Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial, Lancet, 358, 1855, 10.1016/S0140-6736(01)06887-8
Fernandez-Aviles, 2007, Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial, Eur Heart J, 28, 949, 10.1093/eurheartj/ehl461
Scheller, 2003, Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction, J Am Coll Cardiol, 42, 634, 10.1016/S0735-1097(03)00763-0
Le May, 2005, Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study), J Am Coll Cardiol, 46, 417, 10.1016/j.jacc.2005.04.042
D'Souza, 2011, Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis, Eur Heart J, 32, 972, 10.1093/eurheartj/ehq398
Madsen, 1997, Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction, Circulation, 96, 748, 10.1161/01.CIR.96.3.748
Savonitto, 2010, Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel, Br J Anaesth, 104, 285, 10.1093/bja/aep373
Angiolillo, 2012, Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial, JAMA, 307, 265, 10.1001/jama.2011.2002
Cohen, 2003, The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial, J Am Coll Cardiol, 42, 1348, 10.1016/S0735-1097(03)01040-4
Oldgren, 2008, Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment, Eur Heart J, 29, 315, 10.1093/eurheartj/ehm578
Steg, 2010, Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial, JAMA, 304, 1339, 10.1001/jama.2010.1320
Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746
James, 2011, Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial, Br Med J, 342, 10.1136/bmj.d3527
Brieger, 2009, Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. 2004, Chest, 136
Alexander, 2005, Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes, JAMA, 294, 3108, 10.1001/jama.294.24.3108
Bairey Merz, 2004, Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2–4, 2002: executive summary, Circulation, 109, 805, 10.1161/01.CIR.0000116205.96440.FE
Milcent, Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database, Circulation 2007, 115, 833
Kang, 2012, Sex Differences in Management and Mortality of Patients With ST-Elevation Myocardial Infarction (from the Korean Acute Myocardial Infarction National Registry), Am J Cardiol, 109, 787, 10.1016/j.amjcard.2011.11.006
Zhang, 2012, Age-Specific Gender Differences in In-Hospital Mortality by Type of Acute Myocardial Infarction, Am J Cardiol, 109, 1097, 10.1016/j.amjcard.2011.12.001
Mehilli, 2002, Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention, JAMA, 287, 210, 10.1001/jama.287.2.210
Szummer, 2010, Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register, J Intern Med, 268, 40, 10.1111/j.1365-2796.2009.02204.x
James, 2010, Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial, Circulation, 122, 1056, 10.1161/CIRCULATIONAHA.109.933796
Wiviott, 2008, Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38, Circulation, 118, 1626, 10.1161/CIRCULATIONAHA.108.791061
James, 2010, Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial, Eur Heart J, 31, 3006, 10.1093/eurheartj/ehq325
Bartnik, 2004, The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart, Eur Heart J, 25, 1880, 10.1016/j.ehj.2004.07.027
Timmer, 2011, Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention, Circulation, 124, 704, 10.1161/CIRCULATIONAHA.110.985911
De Caterina, 2010, Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options, Eur Heart J, 31, 1557, 10.1093/eurheartj/ehq162
Diaz, 2007, Glucose–insulin–potassium therapy in patients with ST-segment elevation myocardial infarction, JAMA, 298, 2399, 10.1001/jama.298.20.2399
Finfer, 2009, Intensive versus conventional glucose control in critically ill patients, N Engl J Med, 360, 1283, 10.1056/NEJMoa0810625
Ryden, 2007, Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD), Eur Heart J, 28, 88
Senthinathan, 2011, Hyperglycaemia in acute coronary syndromes: summary of NICE guidance, Br Med J, 343, d6646, 10.1136/bmj.d6646
Kosiborod, 2010, Glucose-lowering targets for patients with cardiovascular disease: focus on inpatient management of patients with acute coronary syndromes, Circulation, 122, 2736, 10.1161/CIRCULATIONAHA.109.913368
Bartnik, 2004, Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction, Eur Heart J, 25, 1990, 10.1016/j.ehj.2004.09.021
Hasin, 2005, Recommendations for the structure, organization, and operation of intensive cardiac care units, Eur Heart J, 26, 1676, 10.1093/eurheartj/ehi202
Spencer, 2004, Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective, Arch Intern Med, 164, 733, 10.1001/archinte.164.7.733
Berger, 2008, Relation of length of hospital stay in acute myocardial infarction to postdischarge mortality, Am J Cardiol, 101, 428, 10.1016/j.amjcard.2007.09.090
Grines, 1998, Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction, J Am Coll Cardiol, 31, 967, 10.1016/S0735-1097(98)00031-X
De Luca, 2004, Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge, Circulation, 109, 2737, 10.1161/01.CIR.0000131765.73959.87
Estevez-Loureiro, 2009, Safety and feasibility of returning patients early to their originating centers after transfer for primary percutaneous coronary intervention, Rev Esp Cardiol, 62, 1356
Newby, 2003, Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making, Eur Heart J, 24, 182, 10.1016/S0195-668X(02)00301-9
Kotowycz, 2010, Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction–a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial), Am Heart J, 159
Morrow, 2000, TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy, Circulation, 102, 2031, 10.1161/01.CIR.102.17.2031
Fox, 2007, Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE), Heart, 93, 177, 10.1136/hrt.2005.084830
Lee, 1995, Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators, Circulation, 91, 1659, 10.1161/01.CIR.91.6.1659
Allman, 2002, Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis, J Am Coll Cardiol, 39, 1151, 10.1016/S0735-1097(02)01726-6
St John Sutton, 1994, Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril, Circulation, 89, 68, 10.1161/01.CIR.89.1.68
Beanlands, 2007, F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2), J Am Coll Cardiol, 50, 2002, 10.1016/j.jacc.2007.09.006
La Canna, 2000, Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium, Eur Heart J, 21, 1358, 10.1053/euhj.1999.2038
Perk, 2012, The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Eur Heart J, 33, 1635, 10.1093/eurheartj/ehs092
Thomson, 2003, Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease, Prog Cardiovasc Dis, 45, 459, 10.1053/pcad.2003.YPCAD15
Meine, 2005, Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes, Am J Cardiol, 95, 976, 10.1016/j.amjcard.2004.12.039
Taylor, 1990, Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention, Ann Intern Med, 113, 118, 10.7326/0003-4819-113-2-118
Taylor, 2004, Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials, Am J Med, 116, 682, 10.1016/j.amjmed.2004.01.009
Myers, 2002, Exercise capacity and mortality among men referred for exercise testing, N Engl J Med, 346, 793, 10.1056/NEJMoa011858
Bangalore, 2010, What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial, Circulation, 122, 2142, 10.1161/CIRCULATIONAHA.109.905687
Gulliksson, 2011, Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM), Arch Intern Med, 171, 134, 10.1001/archinternmed.2010.510
Lawler, 2011, Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials, Am Heart J, 162, 10.1016/j.ahj.2011.07.017
Heran, 2011, Exercise-based cardiac rehabilitation for coronary heart disease, Cochrane Database Syst Rev, 10.1002/14651858.CD001800.pub2
West, 2011, Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction, Heart, 98, 637, 10.1136/heartjnl-2011-300302
Giannuzzi, 2008, Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network, Arch Intern Med, 168, 2194, 10.1001/archinte.168.20.2194
Dalal, 2010, Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis, Br Med J, 340, b5631, 10.1136/bmj.b5631
Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1
Capodanno, 2011, Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease, Circ Cardiovasc Interv, 4, 180, 10.1161/CIRCINTERVENTIONS.110.960187
Henry, 2011, 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease, Thromb Haemost, 105, 336, 10.1160/TH10-02-0082
Silberman, 2005, Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting, Am J Cardiol, 95, 509, 10.1016/j.amjcard.2004.10.022
Page, 2007, Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy, Ann Pharmacother, 41, 61, 10.1345/aph.1H437
Rossini, 2008, Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation, Am J Cardiol, 101, 786, 10.1016/j.amjcard.2007.10.045
1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee, Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3
Grines, 2007, Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians, Circulation, 115, 813, 10.1161/CIRCULATIONAHA.106.180944
Gwon, 2012, Six-Month versus Twelve-Month Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents: 'EXCELLENT' Randomized, Multicenter Study, Circulation, 125, 505, 10.1161/CIRCULATIONAHA.111.059022
Park, 2010, Duration of dual antiplatelet therapy after implantation of drug-eluting stents, N Engl J Med, 362, 1374, 10.1056/NEJMoa1001266
Valgimigli, 2010, Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY), Am Heart J, 160, 804, 10.1016/j.ahj.2010.07.034
Mauri, 2010, Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions, Am Heart J, 160
Mehta, 2001, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4
Camm, 2010, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278
Lip, 2010, Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice, Thromb Haemost, 103, 683, 10.1160/TH10-01-0038
Hansen, 2010, Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation, Arch Intern Med, 170, 1433, 10.1001/archinternmed.2010.271
Lip, 2010, Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary–a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Eur Heart J, 31, 1311, 10.1093/eurheartj/ehq117
Faxon, 2011, Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary, Circ Cardiovasc Interv, 4, 522, 10.1161/CIRCINTERVENTIONS.111.965186
Rubboli, 2008, Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation, Ann Med, 40, 428, 10.1080/07853890802089786
Abraham, 2010, ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focussed update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents, J Am Coll Cardiol, 56, 2051, 10.1016/j.jacc.2010.09.010
Gilard, 2008, Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study, J Am Coll Cardiol, 51, 256, 10.1016/j.jacc.2007.06.064
Goodman, 2012, Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes with Clopidogrel and Ticagrelor: Insights from PLATO, Circulation, 10.1161/CIRCULATIONAHA.111.032912
O'Donoghue, 2009, Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials, Lancet, 374, 989, 10.1016/S0140-6736(09)61525-7
Bhatt, 2010, Clopidogrel with or without Omeprazole in Coronary Artery Disease, N Engl J Med, 363, 1909, 10.1056/NEJMoa1007964
Simon, 2010, Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry, Circulation, 123, 474, 10.1161/CIRCULATIONAHA.110.965640
Mega, 2012, Rivaroxaban in Patients with a Recent Acute Coronary Syndrome, N Engl J Med, 366, 9, 10.1056/NEJMoa1112277
Alexander, 2011, Apixaban with antiplatelet therapy after acute coronary syndrome, N Engl J Med, 365, 699, 10.1056/NEJMoa1105819
Steg, 2011, RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome, Eur Heart J, 32, 2541, 10.1093/eurheartj/ehr334
Oldgren, 2011, Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial, Eur Heart J, 32, 2781, 10.1093/eurheartj/ehr113
Chen, 2005, Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet, 366, 1622, 10.1016/S0140-6736(05)67661-1
Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1
Schwartz, 2001, Atorvastatin for acute coronary syndromes, JAMA, 286, 533
Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583
Reiner, 2011, ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J, 32, 1769, 10.1093/eurheartj/ehr158
1999, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, Lancet, 354, 447, 10.1016/S0140-6736(99)07072-5
Kromhout, 2010, n-3 fatty acids cardiovascular events after myocardial infarction, N Engl J Med, 363, 2015, 10.1056/NEJMoa1003603
Rauch, 2010, OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction, Circulation, 122, 2152, 10.1161/CIRCULATIONAHA.110.948562
Yusuf, 1991, Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies, Am J Cardiol, 67, 1295, 10.1016/0002-9149(91)90944-G
1990, Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction, Am J Cardiol, 66
1990, Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II–DAVIT II), Am J Cardiol, 66, 779, 10.1016/0002-9149(90)90351-Z
Poole-Wilson, 2004, Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial, Lancet, 364, 849, 10.1016/S0140-6736(04)16980-8
1995, ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group, Lancet, 345, 669, 10.1016/S0140-6736(95)90865-X
Dickstein, 2002, Effects of losartan captopril on mortality morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan, Lancet, 360, 752, 10.1016/S0140-6736(02)09895-1
Pfeffer, 2003, Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both, N Engl J Med, 349, 1893, 10.1056/NEJMoa032292
Pitt, 2003, Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 348, 1309, 10.1056/NEJMoa030207
Steinhubl, 2002, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial, JAMA, 288, 2411, 10.1001/jama.288.19.2411
Dickstein, 2008, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM), Eur Heart J, 29, 2388, 10.1093/eurheartj/ehn309
Dargie, 2001, Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial, Lancet, 357, 1385, 10.1016/S0140-6736(00)04560-8
Packer, 2001, Effect of carvedilol on survival in severe chronic heart failure, N Engl J Med, 344, 1651, 10.1056/NEJM200105313442201
1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9
Poole-Wilson, 2003, Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial, Lancet, 362, 7, 10.1016/S0140-6736(03)13800-7
Fox, 2003, Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study), Lancet, 362, 782, 10.1016/S0140-6736(03)14286-9
Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301
Vardas, 2007, Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association, Eur Heart J, 28, 2256, 10.1093/eurheartj/ehm305
Goldberg, 2009, Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective, Circulation, 119, 1211, 10.1161/CIRCULATIONAHA.108.814947
Dzavik, 2003, Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry, Eur Heart J, 24, 828, 10.1016/S0195-668X(02)00844-8
Menon, 2000, The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?, J Am Coll Cardiol, 36, 1071, 10.1016/S0735-1097(00)00874-3
Picard, 2003, Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock, Circulation, 107, 279, 10.1161/01.CIR.0000045667.11911.F6
Engstrom, 2010, Right ventricular dysfunction is an independent predictor for mortality in ST-elevation myocardial infarction patients presenting with cardiogenic shock on admission, Eur J Heart Fail, 12, 276, 10.1093/eurjhf/hfp204
Jeger, 2007, Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial, Chest, 132, 1794, 10.1378/chest.07-1336
Alexander, 2007, Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial, JAMA, 297, 1657, 10.1001/jama.297.15.joc70035
Thackray, 2002, The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis, Eur J Heart Fail, 4, 515, 10.1016/S1388-9842(02)00041-7
De Backer, 2010, Comparison of dopamine and norepinephrine in the treatment of shock, N Engl J Med, 362, 779, 10.1056/NEJMoa0907118
Jeger, 2006, Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock–a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry, Am Heart J, 152, 686, 10.1016/j.ahj.2006.06.010
Hussain, 2011, The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators, Catheter Cardiovasc Interv, 78, 540, 10.1002/ccd.23006
Ohman, 2005, Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial, J Thromb Thrombolysis, 19, 33, 10.1007/s11239-005-0938-0
Prondzinsky, 2010, Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome, Crit Care Med, 38, 152, 10.1097/CCM.0b013e3181b78671
Bahekar, 2011, Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis, J Cardiovasc Pharmacol Ther, 17, 44, 10.1177/1074248410395019
Cheng, 2009, Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials, Eur Heart J, 30, 2102, 10.1093/eurheartj/ehp292
Starling, 2011, Results of the post-U .S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support), J Am Coll Cardiol, 57, 1890, 10.1016/j.jacc.2010.10.062
Sheu, 2010, Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock, Crit Care Med, 38, 1810, 10.1097/CCM.0b013e3181e8acf7
McAlister, 2004, Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials, J Am Coll Cardiol, 44, 810
1993, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators, Lancet, 342, 821
Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001
Kober, 1995, A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group, N Engl J Med, 333, 1670, 10.1056/NEJM199512213332503
Taylor, 2004, Combination of isosorbide dinitrate and hydralazine in blacks with heart failure, N Engl J Med, 351, 2049, 10.1056/NEJMoa042934
Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001
Costanzo, 2007, Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure, J Am Coll Cardiol, 49, 675, 10.1016/j.jacc.2006.07.073
Shah, 2005, Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials, JAMA, 294, 1664, 10.1001/jama.294.13.1664
Levy, 2011, Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study, Crit Care Med, 39, 450, 10.1097/CCM.0b013e3181ffe0eb
Bloch Thomsen, 2010, Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study, Circulation, 122, 1258, 10.1161/CIRCULATIONAHA.109.902148
Askari, 2009, The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V, Am Heart J, 158, 238, 10.1016/j.ahj.2009.05.023
Piccini, 2008, Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry), Am J Cardiol, 102, 1427, 10.1016/j.amjcard.2008.07.033
Schmitt, 2009, Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications, Eur Heart J, 30, 1038, 10.1093/eurheartj/ehn579
Jabre, 2011, Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis, Circulation, 123, 1587, 10.1161/CIRCULATIONAHA.110.986661
Segal, 2000, The evidence regarding the drugs used for ventricular rate control, J Fam Pract, 49, 47
Hou, 1995, Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study, Eur Heart J, 16, 521, 10.1093/oxfordjournals.eurheartj.a060945
Zipes, 2006, ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society, Eur Heart J, 27, 2099, 10.1093/eurheartj/ehl199
Hazinski, 2010, Part 1: Executive summary: 010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations, Circulation, 122, 10.1161/CIRCULATIONAHA.110.970897
Marill, 2010, Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison, Acad Emerg Med, 17, 297, 10.1111/j.1553-2712.2010.00680.x
Link, 2010, Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Circulation, 122, 10.1161/CIRCULATIONAHA.110.970954
Hine, 1989, Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction, Arch Intern Med, 149, 2694, 10.1001/archinte.1989.00390120056011
Piccini, 2011, Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction, Crit Care Med, 39, 78, 10.1097/CCM.0b013e3181fd6ad7
Brugada, 2001, Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome, J Am Coll Cardiol, 37, 529, 10.1016/S0735-1097(00)01133-5
Natale, 1994, Ventricular fibrillation and polymorphic ventricular tachycardia with critical coronary artery stenosis: does bypass surgery suffice?, J Cardiovasc Electrophysiol, 5, 988, 10.1111/j.1540-8167.1994.tb01140.x
Lee, 2003, Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis, J Am Coll Cardiol, 41, 1573, 10.1016/S0735-1097(03)00253-5
Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399
Dickstein, 2010, 2010 Focussed Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association, Eur Heart J, 31, 2677, 10.1093/eurheartj/ehq337
Huikuri, 1989, Efficacy of intravenous propranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologic characteristics in coronary artery disease, Am J Cardiol, 64, 1305, 10.1016/0002-9149(89)90572-9
Chevalier, 2004, Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation, Eur J Cardiothorac Surg, 26, 330, 10.1016/j.ejcts.2004.04.027
Topaz, 1992, Interventricular septal rupture complicating acute myocardial infarction: from pathophysiologic features to the role of invasive and non-invasive diagnostic modalities in current management, Am J Med, 93, 683, 10.1016/0002-9343(92)90203-N
Lemery, 1992, Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention, Am J Cardiol, 70, 147, 10.1016/0002-9149(92)91266-7
Imazio, 2009, Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention, Am J Cardiol, 103, 1525, 10.1016/j.amjcard.2009.01.366
Osherov, 2009, Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era, Am Heart J, 157, 1074, 10.1016/j.ahj.2009.03.020
Solheim, 2010, Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy, Am J Cardiol, 106, 1197, 10.1016/j.amjcard.2010.06.043
Porter, 2005, Left ventricular mural thrombus after anterior ST-segment-elevation acute myocardial infarction in the era of aggressive reperfusion therapy–still a frequent complication, Coron Artery Dis, 16, 275, 10.1097/00019501-200508000-00003
Reeder, 1981, Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization, Mayo Clin Proc, 56, 77
Keeley, 1996, Left ventricular mural thrombus after acute myocardial infarction, Clin Cardiol, 19, 83, 10.1002/clc.4960190203